CAS 2763617-39-4

Formel: C22H28N5NaO4S

InChl: InChI=1S/C22H29N5O4S.Na/c1-26-13-17(12-23-26)27(14-18-7-4-10-31-18)32(29,30)25-22(28)24-21-19-8-2-5-15(19)11-16-6-3-9-20(16)21;/h11-13,18H,2-10,14H2,1H3,(H2,24,25,28);/q;+1/p-1/t18-;/m0./s1

InChI Key: VIQOIGVHQODXOY-FERBBOLQSA-M

SMILES: CN1C=C(C=N1)N(C[C@@H]2CCCO2)S(=O)(=O)[N-]C(=O)NC3=C4CCCC4=CC5=C3CCC5.[Na+]

NT-0249

CAS: 2763617-39-4

NT-0249

Formel: C₂₂H₂₈N₅NaO₄S

Reinheit: ≥98%

Molekulargewicht: 481.54

Ref: 54-BUP01628

Sodium (S)-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)((N-(1-methyl-1H-pyrazol-4-yl)-N-((tetrahydrofuran-2-yl)methyl)sulfamoyl)carbamoyl)amide

CAS: 2763617-39-4

Ref: IN-DA02EUFH

NT-0249

CAS: 2763617-39-4

NT-0249 is an inflammatory vesicle NLRP3 inhibitor with anti-inflammatory activity that reverses high-fat diet-induced obesity.

Formel: C₂₂H₂₈N₅NaO₄S

Reinheit: 97.26%

Farbe und Form: Yellow Solid

Molekulargewicht: 481.54

Ref: TM-T85352

NT-0249

CAS: 2763617-39-4

Sodium (S)-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)((N-(1-methyl-1H-pyrazol-4-yl)-N-((tetrahydrofuran-2-yl)methyl)sulfamoyl)carbamoyl)amide

Formel: C₂₂H₂₈N₅NaO₄S

Reinheit: 95%

Molekulargewicht: 481.54

Ref: IN-DG02589230